NB Magazine (the eye health and sight loss magazine for professionals,) which is published by the RNIB recently wrote to us to see if one of our members would be happy to contribute to their column called ‘Patient Perspective’ . This features the experiences of people with sight loss – covering a different eye condition each time, and describing what it’s like living with the condition. Continue reading
A paper entitled “Reappraisal of birdshot retinochoroiditis (BRC): a global approach.” has just been published by M Papdia and C P Herbort. Continue reading
Some of you may know that there have been trials on the drug, Sirolimus, which is given intravitreally or subconjunctivally (i.e. into the eye).
The idea behind this medication is that it should allow us to decrease our use of steroids which have such horrible side-effects, and it tends not to give so many other side effects, and it is not taken systemically (i.e. into our bodies). Continue reading
There has been an overwhelming number of papers being produced on helminthic therapy (worms) recently. This is exciting, as it means that it is a therapy that is being taken seriously, and therefore may well get to trial quite soon. Continue reading
I have already posted about the moves being made in gene therapy. Andrew Dick (who chairs the Birdshot Research Network) and colleagues have published a paper on gene therapy for non infectious uveitis, including severe forms of posterior uveitis such as Birdshot. Continue reading
Stephen Foster and associates have published a paper on Treatment of Birdshot with Infliximab. You may be aware that Stephen Foster is hosting the 2013 Birdshot Day on 28 September 2013, in Boston, United States. He has a profound interest in Birdshot and was instrumental in helping us set up BUS. Continue reading
Birdshot is an inflammatory disease, and if we can find out why we produce this inflammatory response, we may be well along the way to finding a cure. Continue reading
The Shanghai Institutes for Biological Sciences has published a paper on Mesenchymal stem Cells (MSCs). The Institute believes that MSCs are emerging as a promising therapeutic approach of a cell-based therapy for a wide range of auto-immune disorders and degenerative diseases. Continue reading
The next Birdshot Day will be held on 28 September, 2013 in Boston, United States. It is being hosted by Stephen Foster, whom many of you will know. Stephen has been an inspiration for all of us with Birdshot, and held the very first ever Birdshot Day in Boston in 2008. It was this meeting that inspired Annie and I to set up BUS. Continue reading
If you want to help Birdshot Uveitis Society while you do your online shopping don’t forget to sign in to your Easy Fundraising account before you start your shopping. Continue reading